IFN-β, IFN-γ, and TNF-α decrease erythrophagocytosis by human monocytes independent of SIRP-α or SHP-1 expression

References

• Javierre, B.M., Hernando, H., Ballestar, E. Environmental triggers and epigenetic deregulation in autoimmune disease. Discov Med 2011, 12, 535–545.
   PubMed Web of Science ®Google Scholar
• Delogu, L.G., Deidda, S., Delitala, G., Manetti, R. Infectious diseases and autoimmunity. J Infect Dev Ctries 2011, 5, 679–687.
   PubMed Web of Science ®Google Scholar
• Fujinami, R.S., von Herrath, M.G., Christen, U., Whitton, J.L. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev 2006, 19, 80–94.
   PubMed Web of Science ®Google Scholar
• McCoy, L., Tsunoda, I., Fujinami, R.S. Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation. Autoimmunity 2006, 39, 9–19.
   PubMed Web of Science ®Google Scholar
• Musaji, A., Meite, M., Detalle, L., Franquin, S., Cormont, F., Préat, V., Izui, S., Coutelier, J.P. Enhancement of autoantibody pathogenicity by viral infections in mouse models of anemia and thrombocytopenia. Autoimmun Rev 2005, 4, 247–252.
   PubMed Web of Science ®Google Scholar
• Meite, M., Léonard, S., Idrissi, M.E., Izui, S., Masson, P.L., Coutelier, J.P. Exacerbation of autoantibody-mediated hemolytic anemia by viral infection. J Virol 2000, 74, 6045–6049.
   PubMed Web of Science ®Google Scholar
• von Herrath, M.G., Oldstone, M.B. Virus-induced autoimmune disease. Curr Opin Immunol 1996, 8, 878–885.
   PubMed Web of Science ®Google Scholar
• Ramshaw, I.A., Ramsay, A.J., Karupiah, G., Rolph, M.S., Mahalingam, S., Ruby, J.C. Cytokines and immunity to viral infections. Immunol Rev 1997, 159, 119–135.
   PubMed Web of Science ®Google Scholar
• Condino-Neto, A., Whitney, C., Newburger, P.E. Dexamethasone but not indomethacin inhibits human phagocyte nicotinamide adenine dinucleotide phosphate oxidase activity by down-regulating expression of genes encoding oxidase components. J Immunol 1998, 161, 4960–4967.
   PubMed Web of Science ®Google Scholar
• Ray, J.C., Wang, J., Chan, J., Kirschner, D.E. The timing of TNF and IFN-gamma signaling affects macrophage activation strategies during Mycobacterium tuberculosis infection. J Theor Biol 2008, 252, 24–38.
   PubMed Web of Science ®Google Scholar
• Tomioka, H., Sato, K., Maw, W.W., Saito, H. The role of tumor necrosis factor, interferon-gamma, transforming growth factor-beta, and nitric oxide in the expression of immunosuppressive functions of splenic macrophages induced by Mycobacterium avium complex infection. J Leukoc Biol 1995, 58, 704–712.
   PubMed Web of Science ®Google Scholar
• Fluhr, H., Krenzer, S., Stein, G.M., Stork, B., Deperschmidt, M., Wallwiener, D., Wesselborg, S., Zygmunt, M., Licht, P. Interferon-gamma and tumor necrosis factor-alpha sensitize primarily resistant human endometrial stromal cells to Fas-mediated apoptosis. J Cell Sci 2007, 120, 4126–4133.
   PubMed Web of Science ®Google Scholar
• Suk, K., Kim, S., Kim, Y.H., Kim, K.A., Chang, I., Yagita, H., Shong, M., Lee, M.S. IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death. J Immunol 2001, 166, 4481–4489.
   PubMed Web of Science ®Google Scholar
• Hosseini-Moghaddam, S.M., Mousavi, A., Alavian, S.M. Is {beta}-interferon a promising therapeutic option for the management of hepatitis C? J Antimicrob Chemother 2009, 63, 1097–1103.
   PubMed Web of Science ®Google Scholar
• Crow, M.K. Type I interferon in organ-targeted autoimmune and inflammatory diseases. Arthritis Res Ther 2010, 12 Suppl 1, S5.
   PubMedGoogle Scholar
• Olsson, M., Nilsson, A., Oldenborg, P.A. Target cell CD47 regulates macrophage activation and erythrophagocytosis. Transfus Clin Biol 2006, 13, 39–43.
   PubMed Web of Science ®Google Scholar
• Ishikawa-Sekigami, T., Kaneko, Y., Okazawa, H., Tomizawa, T., Okajo, J., Saito, Y., Okuzawa, C., Sugawara-Yokoo, M., Nishiyama, U., Ohnishi, H., Matozaki, T., Nojima, Y. SHPS-1 promotes the survival of circulating erythrocytes through inhibition of phagocytosis by splenic macrophages. Blood 2006, 107, 341–348.
   PubMed Web of Science ®Google Scholar
• Jaiswal, S., Jamieson, C.H., Pang, W.W., Park, C.Y., Chao, M.P., Majeti, R., Traver, D., van Rooijen, N., Weissman, I.L. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 2009, 138, 271–285.
   PubMed Web of Science ®Google Scholar
• Majeti, R., Chao, M.P., Alizadeh, A.A., Pang, W.W., Jaiswal, S., Gibbs, K.D. Jr, van Rooijen, N., Weissman, I.L. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell 2009, 138, 286–299.
   PubMed Web of Science ®Google Scholar
• Spaargaren, M. Lymphoma spread? Target CD47-SIRPa! Blood 2011, 118, 4762–4764.
   PubMed Web of Science ®Google Scholar
• Chao, M.P., Tang, C., Pachynski, R.K., Chin, R., Majeti, R., Weissman, I.L. Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy. Blood 2011, 118, 4890–4901.
   PubMed Web of Science ®Google Scholar
• Ide, M., Ohnishi, T., Murayama, M., Matsumoto, I., Yamada, K., Iwayama, Y., Dedova, I., Toyota, T., Asada, T., Takashima, A., Yoshikawa, T. Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia. J Neurochem 2006, 99, 277–287.
   PubMed Web of Science ®Google Scholar
• Waern, J.M., Yuan, Q., Rüdrich, U., Becker, P.D., Schulze, K., Strick-Marchand, H., Huntington, N.D., Zacher, B.J., Wursthorn, K., Di Santo, J.P., Guzman, C.A., Manns, M.P., Ott, M., Bock, M. Ectopic expression of murine CD47 minimizes macrophage rejection of human hepatocyte xenografts in immunodeficient mice. Hepatology 2012 (in press).
   Web of Science ®Google Scholar
• Scalea, J., Hanecamp, I., Robson, S.C., Yamada, K. T-cell-mediated immunological barriers to xenotransplantation. Xenotransplantation 2012, 19, 23–30.
   PubMed Web of Science ®Google Scholar
• Raymond, M., Rubio, M., Fortin, G., Shalaby, K.H., Hammad, H., Lambrecht, B.N., Sarfati, M. Selective control of SIRP-alpha-positive airway dendritic cell trafficking through CD47 is critical for the development of T(H)2-mediated allergic inflammation. J Allergy Clin Immunol 2009, 124, 1333–42.e1.
   PubMed Web of Science ®Google Scholar
• Verjan Garcia, N., Umemoto, E., Saito, Y., Yamasaki, M., Hata, E., Matozaki, T., Murakami, M., Jung, Y.J., Woo, S.Y., Seoh, J.Y., Jang, M.H., Aozasa, K., Miyasaka, M. SIRPa/CD172a regulates eosinophil homeostasis. J Immunol 2011, 187, 2268–2277.
   PubMed Web of Science ®Google Scholar
• Healey, G., Veale, M.F., Sparrow, R.L. A fluorometric quantitative erythrophagocytosis assay using human THP-1 monocytic cells and PKH26-labelled red blood cells. J Immunol Methods 2007, 322, 50–56.
   PubMed Web of Science ®Google Scholar
• Montgomery, D.C. Design and analysis of experiments. 3rd ed. New York: John Wiley & Sons; 1991.
   Google Scholar
• Jungi, T.W., Brcic, M., Leutwyler, C., Pfister, H., Spycher, M.O. Interferon-gamma treatment impairs Fc receptor type II-mediated phagocytosis of human macrophages by a post-receptor-binding mechanism. Immunology 1991, 74, 439–445.
   PubMed Web of Science ®Google Scholar
• Fratti, R.A., Ghannoum, M.A., Edwards, J.E. Jr, Filler, S.G. Gamma interferon protects endothelial cells from damage by Candida albicans by inhibiting endothelial cell phagocytosis. Infect Immun 1996, 64, 4714–4718.
   PubMed Web of Science ®Google Scholar
• Willenborg, D.O., Fordham, S.A., Staykova, M.A., Ramshaw, I.A., Cowden, W.B. IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. J Immunol 1999, 163, 5278–5286.
   PubMed Web of Science ®Google Scholar
• Willenborg, D.O., Staykova, M.A., Cowden, W.B. Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: a review. J Neuroimmunol 1999, 100, 21–35.
   PubMed Web of Science ®Google Scholar
• Park, H., Li, Z., Yang, X.O., Chang, S.H., Nurieva, R., Wang, Y.H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., Dong, C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005, 6, 1133–1141.
   PubMed Web of Science ®Google Scholar
• Isomäki, P., Panesar, M., Annenkov, A., Clark, J.M., Foxwell, B.M., Chernajovsky, Y., Cope, A.P. Prolonged exposure of T cells to TNF down-regulates TCR zeta and expression of the TCR/CD3 complex at the cell surface. J Immunol 2001, 166, 5495–5507.
   PubMed Web of Science ®Google Scholar
• Kassiotis, G., Kollias, G. Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. J Exp Med 2001, 193, 427–434.
   PubMed Web of Science ®Google Scholar
• Zakharova, M., Ziegler, H.K. Paradoxical anti-inflammatory actions of TNF-alpha: inhibition of IL-12 and IL-23 via TNF receptor 1 in macrophages and dendritic cells. J Immunol 2005, 175, 5024–5033.
   PubMed Web of Science ®Google Scholar
• de Almeida, A.C., Barbosa, S.M., Barjas-Castro, M.d.e.L., Olalla-Saad, S.T., Condino-Neto, A. The role of glucocorticoid in SIRP alpha and SHP-1 gene expression in AIHA patients. Immunopharmacol Immunotoxicol 2009, 31, 636–640.
   PubMed Web of Science ®Google Scholar
• Burger, P., Hilarius-Stokman, P., de Korte, D., van den Berg, T.K., van Bruggen, R. CD47 functions as a molecular switch for erythrocyte phagocytosis. Blood 2012, 119, 5512–5521.
   PubMed Web of Science ®Google Scholar
• Babic, I., Schallhorn, A., Lindberg, F.P., Jirik, F.R. SHPS-1 induces aggregation of Ba/F3 pro-B cells via an interaction with CD47. J Immunol 2000, 164, 3652–3658.
   PubMed Web of Science ®Google Scholar
• Tada, K., Tanaka, M., Hanayama, R., Miwa, K., Shinohara, A., Iwamatsu, A., Nagata, S. Tethering of apoptotic cells to phagocytes through binding of CD47 to Src homology 2 domain-bearing protein tyrosine phosphatase substrate-1. J Immunol 2003, 171, 5718–5726.
   PubMed Web of Science ®Google Scholar